Literature DB >> 28676713

Effect of the meropenem MIC on the killing activity of meropenem and polymyxin B in combination against KPC-producing Klebsiella pneumoniae.

Brandon Kulengowski1, Jeffrey J Campion2, David J Feola1, David S Burgess1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28676713     DOI： 10.1038/ja.2017.73

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  15 in total

Review 1.  Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use.

Authors:  Phillip J Bergen; Zackery P Bulman; Sarith Saju; Juergen B Bulitta; Cornelia Landersdorfer; Alan Forrest; Jian Li; Roger L Nation; Brian T Tsuji
Journal:  Pharmacotherapy       Date:  2015-01       Impact factor: 4.705

2.  Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae.

Authors:  George A Pankey; Deborah S Ashcraft
Journal:  Diagn Microbiol Infect Dis       Date:  2011-08       Impact factor: 2.803

3.  Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.

Authors:  Simona Bratu; Pooja Tolaney; Usha Karumudi; John Quale; Mohamad Mooty; Satyen Nichani; David Landman
Journal:  J Antimicrob Chemother       Date:  2005-05-25       Impact factor: 5.790

4.  Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens.

Authors:  Zubair A Qureshi; David L Paterson; Brian A Potoski; Mary C Kilayko; Gabriel Sandovsky; Emilia Sordillo; Bruce Polsky; Jennifer M Adams-Haduch; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

5.  Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae.

Authors:  Brandon Kitchel; J Kamile Rasheed; Andrea Endimiani; Andrea M Hujer; Karen F Anderson; Robert A Bonomo; Jean B Patel
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

6.  Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems.

Authors:  George L Daikos; Sophia Tsaousi; Leonidas S Tzouvelekis; Ioannis Anyfantis; Mina Psichogiou; Athina Argyropoulou; Ioanna Stefanou; Vana Sypsa; Vivi Miriagou; Martha Nepka; Sarah Georgiadou; Antonis Markogiannakis; Dimitris Goukos; Athanasios Skoutelis
Journal:  Antimicrob Agents Chemother       Date:  2014-02-10       Impact factor: 5.191

Review 7.  Combination therapy for carbapenem-resistant Gram-negative bacteria.

Authors:  Mical Paul; Yehuda Carmeli; Emanuele Durante-Mangoni; Johan W Mouton; Evelina Tacconelli; Ursula Theuretzbacher; Cristina Mussini; Leonard Leibovici
Journal:  J Antimicrob Chemother       Date:  2014-05-28       Impact factor: 5.790

Review 8.  Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems.

Authors:  Oren Zusman; Tomer Avni; Leonard Leibovici; Amos Adler; Lena Friberg; Theodouli Stergiopoulou; Yehuda Carmeli; Mical Paul
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

9.  In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae.

Authors:  Anima Poudyal; Benjamin P Howden; Jan M Bell; Wei Gao; Roxanne J Owen; John D Turnidge; Roger L Nation; Jian Li
Journal:  J Antimicrob Chemother       Date:  2008-10-15       Impact factor: 5.790

10.  Carbapenem-resistant Pseudomonas aeruginosa-carrying VIM-2 metallo-beta-lactamase determinants, Croatia.

Authors:  Sanda Sardelic; Lucia Pallecchi; Volga Punda-Polic; Gian Maria Rossolini
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.